In many developing countries, there is lack of essential medicines for main diseases that affect the population. The countries generally do not have the capacities to manufacture their own drugs, and usually depend on medicines developed and produced in wealthy countries to meet local needs. Multinational pharmaceutical companies are reluctant to produce drugs solely for the developing country diseases because of the low purchasing power. Weak infrastructure for industry and technology, shortage of researchers and limited financial resources are among the reasons for lack of adequate pharmaceutical production in poor countries. There are global initiatives to increase accessibility to medicines for some neglected diseases and the international community is encouraging local production of pharmaceuticals as a possible means to make medicines available in developing countries. Nonetheless, some developing countries are able to produce pharmaceuticals locally, primarily generics that cover some percentage of local drug need, while few others are able to produce and export finished products and active pharmaceutical ingredients (APIs) mainly to other developing nations. The article explored issues of access to quality medicines and local production of pharmaceuticals in developing countries and the factors influencing this industry.
Mendeley saves you time finding and organizing research
Choose a citation style from the tabs below